- Home
- SQM vs QGEN Comparison
SQM vs QGEN Comparison
Compare SQM & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQM
- QGEN
- Stock Information
- Founded
- SQM 1968
- QGEN 1986
- Country
- SQM Chile
- QGEN Netherlands
- Employees
- SQM N/A
- QGEN N/A
- Industry
- SQM Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SQM Industrials
- QGEN Health Care
- Exchange
- SQM Nasdaq
- QGEN Nasdaq
- Market Cap
- SQM 9.9B
- QGEN 9.1B
- IPO Year
- SQM 1993
- QGEN 1996
- Fundamental
- Price
- SQM $37.00
- QGEN $48.34
- Analyst Decision
- SQM Buy
- QGEN Buy
- Analyst Count
- SQM 7
- QGEN 9
- Target Price
- SQM $41.14
- QGEN $50.79
- AVG Volume (30 Days)
- SQM 1.1M
- QGEN 1.3M
- Earning Date
- SQM 08-19-2025
- QGEN 07-30-2025
- Dividend Yield
- SQM 5.69%
- QGEN 3.10%
- EPS Growth
- SQM 53.25
- QGEN N/A
- EPS
- SQM 2.11
- QGEN 0.42
- Revenue
- SQM $4,480,874,000.00
- QGEN $2,002,874,000.00
- Revenue This Year
- SQM N/A
- QGEN $6.36
- Revenue Next Year
- SQM $20.12
- QGEN $6.18
- P/E Ratio
- SQM $17.61
- QGEN $114.96
- Revenue Growth
- SQM N/A
- QGEN 3.31
- 52 Week Low
- SQM $29.36
- QGEN $37.63
- 52 Week High
- SQM $45.89
- QGEN $48.82
- Technical
- Relative Strength Index (RSI)
- SQM 68.83
- QGEN 70.56
- Support Level
- SQM $34.44
- QGEN $47.65
- Resistance Level
- SQM $36.13
- QGEN $48.82
- Average True Range (ATR)
- SQM 1.18
- QGEN 0.71
- MACD
- SQM 0.53
- QGEN 0.01
- Stochastic Oscillator
- SQM 87.30
- QGEN 87.63
About SQM Sociedad Quimica y Minera S.A.
Sociedad Quimica y Minera de Chile is a Chilean commodities producer with significant operations in lithium (primarily used in batteries for electric vehicles and energy storage systems), specialty and standard potassium fertilizers, iodine (primarily used in X-ray contrast media), and solar salts. The company extracts these materials through its high-quality salt brine deposits and caliche ore. SQM is developing a hard rock lithium project in Australia and expanding its lithium refining assets in China.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).